It is not suitable for people with a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, and it may interact with other medications
Single-cell, omics studies of human L-cells, which secrete GLP-1 and 2, may uncover regulatory networks controlling incretin secretion
Cancer Discov 12(1):3146
Tempia Valenta S, Nicastri A, Perazza F, Marcolini F, Beghelli V, Atti AR, et al
Compounding is useful for patients who may have allergies to certain ingredients in commercial drugs or require unique dosages that aren't available in pre-made medications
Gastrointestinal side effects comparison Retatrutide has a notably higher GI side effect burden at maximum doses